• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11013

【品名】diethyl (2S)-2-aminopentanedioate

【CA登记号】

【 分 子 式 】C9H17NO4

【 分 子 量 】203.23832

【元素组成】C 53.19% H 8.43% N 6.89% O 31.49%

与该中间体有关的原料药合成路线共 15 条

合成路线1

该中间体在本合成路线中的序号:(IX)

A new synthesis for edatrexate has been described: The reaction of 2,4-diamino-6-(bromomethyl)pteridine (I) with tributylphosphine (II) in DMSO gives the corresponding phosphonium salt (III), which is condensed wtih 4-propionylbenzoic acid methyl ester (IV) by means of NaH in DMSO, affording 4-[1-(2,4-diaminopteridin-6-yl)-1-ethylvinyl]benzoic acid methyl ester (V). The hydrogenation of (V) with H2 and PtO2 in acetic acid gives 4-[1-(2,4-diamino-6,7-dihydropteridin-6-ylmethyl)propyl]benzoic acid methyl ester (VI), which, without isolation, is dehydrogenated with H2O2 in the same solvent yielding 4-[1-(2,4-diaminopteridin-6-ylmethyl)propyl]benzoic acid methyl ester (VII). The hydrolysis of (VII) with NaOH in DMSO - water affords the corresponding free acid (VIII), which is condensed with L-glutamic acid diethyl ester (IX) by means of isobutoxycarbonylchloride and triethylamine in DMF, giving edatrexate diethyl ester (X). Finally, this compound is hydrolyzed with NaOH in methanol.

1 Johnson, C.A.; Sirotnak, F.M.; Piper, J.R.; Otter, G.M.; Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10-dideazaaminopterin and an alternative synthesis of 10-ethyl-10-deazaaminopterin (edatrexate). J Med Chem 1992, 35, 16, 3002.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11006 2-Amino-6-(bromomethyl)-4-pteridinylamine; 6-(Bromomethyl)-2,4-pteridinediamine 52853-40-4 C7H7BrN6 详情 详情
(III) 11007 Tributyl[(2,4-diamino-6-pteridinyl)methyl]phosphonium bromide C19H34BrN6P 详情 详情
(IV) 11008 methyl 4-propionylbenzoate C11H12O3 详情 详情
(V) 11009 methyl 4-[(E)-2-(2,4-diamino-6-pteridinyl)-1-ethylethenyl]benzoate C18H18N6O2 详情 详情
(VI) 11010 methyl 4-[1-[(2,4-diamino-5,6,7,8-tetrahydro-6-pteridinyl)methyl]propyl]benzoate C18H24N6O2 详情 详情
(VII) 11011 methyl 4-[1-[(2,4-diamino-6-pteridinyl)methyl]propyl]benzoate C18H20N6O2 详情 详情
(VIII) 11012 4-[1-[(2,4-Diamino-6-pteridinyl)methyl]propyl]benzoic acid C17H18N6O2 详情 详情
(IX) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(X) 11014 diethyl (2S)-2-[(4-[1-[(2,4-diamino-6-pteridinyl)methyl]propyl]benzoyl)amino]pentanedioate C26H33N7O5 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The acylation of diethyl L-glutamate (I) with 5-nitro-2-thienylcarbonyl chloride (II) in toluene gives N-(5-nitrothien-2-ylcarbonyl)-L-glutamic acid diethyl ester (III), which is reduced with sodium dithionite in ethanol/water to the corresponding amino compound (IV). The methylation of (IV) with methyl iodide and 2,6-lutidine yields the corresponding methylamine (V), which is condensed with 6-(bromomethyl)-2-methylquinazolin-4(3H)-one (VI) by means of 2,6-lutidine in hot DMF affording the diethyl ester (VIII) of D-1694. Finally, this compound is hydrolyzed with NaOH in ethanol/water. The bromomethyl quinazoline (VI) was obtained by selective radical bromination of 2,6-dimethylquinazolin-4(3H)-one (VII) with N-bromosuccinimide (NBS) and benzoyl peroxide in hot chloroform.

1 Lohmeyer, M.; Castaner, J.; Tomudex (TM). Drugs Fut 1995, 20, 4, 371.
2 Hughes, L.R. (AstraZeneca plc; National Research Development Corp.); Anti-tumor quinazolines. EP 0239362; GB 2188319; JP 1989125373; US 4992550; US 5081124; US 5187167 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(II) 12467 5-Nitro-2-thiophenecarbonyl chloride C5H2ClNO3S 详情 详情
(III) 12468 diethyl (2S)-2-[[(5-nitro-2-thienyl)carbonyl]amino]pentanedioate C14H18N2O7S 详情 详情
(IV) 12469 diethyl (2S)-2-[[(5-amino-2-thienyl)carbonyl]amino]pentanedioate C14H20N2O5S 详情 详情
(V) 12470 diethyl (2S)-2-([[5-(methylamino)-2-thienyl]carbonyl]amino)pentanedioate 112889-02-8 C15H22N2O5S 详情 详情
(VI) 12471 6-(Bromomethyl)-2-methyl-4(3H)-quinazolinone C10H9BrN2O 详情 详情
(VII) 12472 2,6-Dimethyl-4(3H)-quinazolinone C10H10N2O 详情 详情
(VIII) 12473 diethyl (2S)-2-[[(5-[methyl[(2-methyl-4-oxo-3,4-dihydro-6-quinazolinyl)methyl]amino]-2-thienyl)carbonyl]amino]pentanedioate C25H30N4O6S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XX)

The reduction of 4-bromophenylacetic acid (I) with boron hydride gives 2-(4-bromophenyl)ethanol (II), which is mesylated with methanesulfonyl chloride to the sulfonate (III). The condensation of (III) with diethyl malonate (IV) by means of NaH yields 2-[2-(4-bromophenyl)ethyl]malonic acid diethyl ester (V), which is reduced with LiAlH4 to the diol (VI). The enantioselective transesterification of (VI) with methyl acetate by means of porcine pancreatic lipase (PPL, Sigma type II, no. 3126) affords the (R)-enantiomer of monoester (VII), which is treated with tert-butyldimethylsilyl chloride in dichloromethane, giving the (S)-enantiomer of the silylated acetoxy derivative (VIII). The hydrolysis of (VIII) with methanolic NaOH yields the silylated alcohol (IX), which is mesylated with methanesulfonyl chloride as before affording the sulfonate (X). The reaction of (X) with sodium azide in hot DMF gives 1-azido-4-(4-bromophenyl)-2(S)-(tert-butyldimethylsilyloxymethyl)butane (XIII), which is deprotected with acetic acid in THF yielding 2(S)-(azidomethyl)-4-(4-bromophenyl)butanol (XII). Mesylation of (XII) as before affords sulfonate (XIII), which is condensed with diethyl malonate (IV) by means of NaH as before, giving the chiral malonate derivative (XIV). The cyclization of (XIV) by means of tributyl phosphine in THF yields (3RS,5R)-5-[2-(4-bromophenyl)ethyl]-2-oxopiperidine-3-carboxylic acid ethyl ester (XV), which is treated with trimethyloxonium tetrafluoroborate in CHCl3 to afford the methoxy derivative (XVI). Cyclization of (XVI) with guanidine hydrochloride (XXII) by means of sodium ethoxide in hot ethanol gives 2-amino-6(R)-[2-(4-bromophenyl)ethyl]-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine (XVII), which is treated with copper cyanide in refluxing 1-methyl-2-pyrrolidone, yielding the nitrile (XVIII). Hydrolysis of (XVIII) with refluxing 6N HCl affords the corresponding benzoic acid (XIX), which is condensed with L-glutamic acid diethyl ester (XX) by means of N-methylmorpholine and 2-chloro-4,6-dimethoxy-1,3,5-triazine in DMF, affording the diethyl ester of the desired product (XXI). Finally, this compound is hydrolyzed with 1N NaOH.

1 Barnett, C.J.; Wilson, T.M. (Eli Lilly and Company); Enantioselective synthesis of antifolates. EP 0417212 .
2 Barnett, C.J.; Wilson, T.M.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Tetrahedron Lett 1989, 30, 46, 6291.
3 Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
4 Wilson, T.M.; Barnett, C.J.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Chemistry and Biology of Pteridines (1989): Pteridines and Folic Acid Derivatives. H.-C. Curtius, S. Ghisla and N. Blau (Eds.). de Gruyter, New York 1990, 102.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14247 2-(4-Bromophenyl)acetic acid; p-Bromophenylacetic acid; 4-Bromophenylacetic acid 1878-68-8 C8H7BrO2 详情 详情
(II) 14248 2-(4-Bromophenyl)-1-ethanol; 4-Bromophenethyl alcohol;2-(4-bromophenyl)ethanol;2-(4-Bromophenyl)ethan-1-ol 4654-39-1 C8H9BrO 详情 详情
(III) 14249 4-Bromophenethyl methanesulfonate C9H11BrO3S 详情 详情
(IV) 16829 Diethyl malonate 105-53-3 C7H12O4 详情 详情
(V) 14251 diethyl 2-(4-bromophenethyl)malonate C15H19BrO4 详情 详情
(VI) 14252 2-(4-Bromophenethyl)-1,3-propanediol C11H15BrO2 详情 详情
(VII) 14253 (2R)-4-(4-bromophenyl)-2-(hydroxymethyl)butyl acetate C13H17BrO3 详情 详情
(VIII) 14254 (2S)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl acetate C19H31BrO3Si 详情 详情
(IX) 14255 (2S)-4-(4-Bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-butanol C17H29BrO2Si 详情 详情
(X) 14256 (2R)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl methanesulfonate C18H31BrO4SSi 详情 详情
(XI) 14257 [[(2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl]oxy](tert-butyl)dimethylsilane; (2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl tert-butyl(dimethyl)silyl ether C17H28BrN3OSi 详情 详情
(XII) 14258 (2S)-2-(Azidomethyl)-4-(4-bromophenyl)-1-butanol C11H14BrN3O 详情 详情
(XIII) 14259 (2S)-2-(azidomethyl)-4-(4-bromophenyl)butyl methanesulfonate C12H16BrN3O3S 详情 详情
(XIV) 14260 diethyl 2-[(2R)-2-(azidomethyl)-4-(4-bromophenyl)butyl]malonate C18H24BrN3O4 详情 详情
(XV) 14261 ethyl (5R)-5-(4-bromophenethyl)-2-oxohexahydro-3-pyridinecarboxylate C16H20BrNO3 详情 详情
(XVI) 14268 ethyl (5R)-5-(4-bromophenethyl)-2-methoxy-3,4,5,6-tetrahydro-3-pyridinecarboxylate C17H22BrNO3 详情 详情
(XVII) 14263 (6R)-2-Amino-6-(4-bromophenethyl)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-4(3H)-one C15H17BrN4O 详情 详情
(XVIII) 14264 4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzonitrile C16H17N5O 详情 详情
(XIX) 14265 4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoic acid C16H18N4O3 详情 详情
(XX) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XXI) 14267 diethyl (2S)-2-[(4-[2-[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate C25H33N5O6 详情 详情
(XXII) 14262 Guanidine hydrochloride 50-01-1 CH5N3.HCl 详情 详情

合成路线4

该中间体在本合成路线中的序号:(VI*)

Racemic lometrexol has been prepared.

1 Okazaki, S.; Asao, T.; Wakida, M.; Ishida, K.; Washinosu, M.; Utsugi, T.; Yamada, Y. (Taiho Pharmaceutical Co., Ltd.); Novel fused indan deriv. and pharmaceutically acceptable salt. EP 0713870; US 5710162; US 5733918; WO 9532187 .
2 Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI*) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(I) 14269 2,4-Diaminopyrido[2,3-d]pyrimidine-6-carbonitrile C8H6N6 详情 详情
(II) 14270 2,4-Diaminopyrido[2,3-d]pyrimidine-6-carbaldehyde C8H7N5O 详情 详情
(III) 14271 [4-(Methoxycarbonyl)benzyl](diphenyl)phosphonium C21H20O2P 详情 详情
(IV) 14272 methyl 4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoate C17H15N5O2 详情 详情
(V) 14273 4-[(E)-2-(2-Amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid C16H12N4O3 详情 详情
(VII) 14275 diethyl (2S)-2-([4-[(E)-2-(2-amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoyl]amino)pentanedioate C25H27N5O6 详情 详情
(VIII) 14276 diethyl (2S)-2-([4-[2-(2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl]amino)pentanedioate C25H33N5O6 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XIV)

Racemic lometrexol has been prepared.

1 Harrington, P.M.; Shih, C.; Grindey, G.B.; Gossett, L.S.; Moran, R.G.; Taylor, S.C.; Synthesis and structure-activity relationship studies of 5,10-dideazatetrahydrofolic acid (DDATHF). Chemistry and Biology of Pteridines (1989): Pteridines and Folic Acid Derivatives. H.-C. Curtius, S. Ghisla and N. Blau (Eds.). de Gruyter, New York 1990, 1035.
2 Taylor, E.C.; Wong, G.S.K.; Convergent and efficient palladium-effected synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). J Org Chem 1989, 54, 15, 3618.
3 Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
51602 1-Propyne C3H4 详情 详情
(I) 14277 2,6-Diamino-4(3H)-pyrimidinone C4H6N4O 详情 详情
(II) 14278 2-Bromomalonaldehyde C3H3BrO2 详情 详情
(III) 14279 2-Amino-6-bromopyrido[2,3-d]pyrimidin-4(3H)-one C7H5BrN4O 详情 详情
(IV) 14280 N-(6-Bromo-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide C12H13BrN4O2 详情 详情
(V) 14281 2,2-Dimethyl-N-[4-oxo-6-[2-(trimethylsilyl)ethynyl]-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl]propanamide C17H22N4O2Si 详情 详情
(VI) 14282 N-(6-Ethynyl-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide C14H14N4O2 详情 详情
(VII) 14283 diethyl (2S)-2-[(4-iodobenzoyl)amino]pentanedioate C16H20INO5 详情 详情
(VIII) 14284 diethyl (2S)-2-[[4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoyl]amino]pentanedioate C30H33N5O7 详情 详情
(IX) 14285 tert-butyl 4-ethynylbenzoate C13H14O2 详情 详情
(X) 14286 tert-butyl 4-bromobenzoate C11H13BrO2 详情 详情
(XI) 14287 diethyl (2S)-2-[(4-ethynylbenzoyl)amino]pentanedioate C18H21NO5 详情 详情
(XII) 14288 tert-butyl 4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoate C25H26N4O4 详情 详情
(XIII) 14289 4-(2-[2-[(2,2-Dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoic acid C21H18N4O4 详情 详情
(XIV) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XV) 14291 diethyl (2S)-2-[[4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl)benzoyl]amino]pentanedioate C30H41N5O7 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XIII)

Racemic lometrexol has been prepared.

1 Taylor, E.C.; Beardsley, G.P.; Harrington, P.J.; Fletcher, S.R. (Princeton University); Pyrido[2,3-d]pyrimidin derivs. AU 8655108; EP 0215063; ES 8704167; ES 8801268; JP 1996193084; WO 8605181 .
2 Beardsley, G.P.; Taylor, E.C.; Shih, C.J.; Wong, G.S.K.; Fletcher, S.R.; Harrington, P.J.; Synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF) and analogs. Chemistry and Biology of Pteridines (1986): Pteridines and Folic Acid Derivatives. B.A. Cooper and V.M. Whitehead (Eds.). de Gruyter, Berlin 1986, 61.
3 Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
14790 Guanidine 113-00-8 CH5N3 详情 详情
(I) 14299 5-Methyl-2-thioxo-2,3-dihydro-3-pyridinecarbonitrile C7H6N2S 详情 详情
(II) 14300 5-Methyl-2-[(4-nitrophenyl)sulfanyl]nicotinonitrile C13H9N3O2S 详情 详情
(III) 14301 5-(Bromomethyl)-2-[(4-nitrophenyl)sulfanyl]nicotinonitrile C13H8BrN3O2S 详情 详情
(IV) 14302 ([6-[(4-Nitrophenyl)sulfanyl]-3-pyridinyl]methyl)(triphenyl)phosphonium bromide C30H24BrN2O2PS 详情 详情
(V) 14303 tert-butyl 4-formylbenzoate C12H14O3 详情 详情
(VI) 14304 tert-butyl 4-((E)-2-[5-cyano-6-[(4-nitrophenyl)sulfanyl]-3-pyridinyl]ethenyl)benzoate C25H21N3O4S 详情 详情
(VII) 14305 tert-butyl 4-[(E)-2-(6-amino-5-cyano-3-pyridinyl)ethenyl]benzoate C19H19N3O2 详情 详情
(VIII) 14306 tert-butyl 4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoate C20H21N5O2 详情 详情
(IX) 14307 4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid C16H13N5O2 详情 详情
(X) 14273 4-[(E)-2-(2-Amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid C16H12N4O3 详情 详情
(XI) 14309 acetic 4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]-1-benzenecarboxylic anhydride C20H16N4O5 详情 详情
(XII) 14310 4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]benzoic acid C18H14N4O4 详情 详情
(XIII) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XIV) 14311 diethyl (2S)-2-[(4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]benzoyl)amino]pentanedioate C27H29N5O7 详情 详情
(XV) 14312 diethyl (2S)-2-[(4-[2-[2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate C27H35N5O7 详情 详情
(XVI) 14313 diethyl (2S)-2-[(4-[2-[(6R)-2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate C27H35N5O7 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XXI)

2) The reaction of 4-(2-formylethyl)benzoic acid ethyl ester (XIV) with paraformaldehyde (XV) by means of N-ethylbenzothiazolium bromide (XVI) and triethylamine gives the 4-hydroxy-3-oxobutyl derivative (XVII), which is condensed with ethyl cyanoacetate (I) by means of triethylamine in ethanol yielding the furancarboxylate derivative (XVIII). The cyclization of (XVIII) with guanidine (IV) by means of sodium ethoxide in ethanol affords 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl] benzoic acid ethyl ester (XIX), which is saponified with NaOH to the corresponding free acid (XX). The condensation of (XX) with L-glutamic acid diethyl ester (XXI) in the usual way affords the diethyl ester of LY-231514 (XXII), which is finally saponified with NaOH.

1 Castaner, J.; Graul, A.; Tracy, M.; Penetrexed Disodium. Drugs Fut 1998, 23, 5, 498.
2 Taylor, E.C.; Patel, H.H. (Princeton University); Process for the preparation of pyrrolo[2,3-d]pyrimidines. CA 2084490 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11877 Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate 105-56-6 C5H7NO2 详情 详情
(IV) 14470 2-[(4R)-3,4-dihydro-2H-chromen-4-yl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide C19H21NO3 详情 详情
(XIV) 14800 ethyl 4-(3-oxopropyl)benzoate C12H14O3 详情 详情
(XVI) 14801 3-Ethylbenzothiazolium bromide; 3-Ethyl-1,3-benzothiazol-3-ium bromide 32446-47-2 C9H10BrNS 详情 详情
(XVII) 14802 Ethyl 4-(4-hydroxy-3-oxobutyl)benzoate C13H16O4 详情 详情
(XVIII) 14803 Ethyl 2-amino-4-[4-(ethoxycarbonyl)phenethyl]-3-furoate C18H21NO5 详情 详情
(XIX) 14804 Ethyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate C17H18N4O3 详情 详情
(XX) 14805 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid C15H14N4O3 详情 详情
(XXI) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XXII) 14807 diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate C24H29N5O6 详情 详情

合成路线8

该中间体在本合成路线中的序号:(X)

A concise and scalable synthesis of pemetrexed disodium has been presented: The alkylation of methyl 4-bromobenzoate (I) with 3-butyn-1-ol (II) by means of Pd(0) gives methyl 4-(4-hydroxy-1-butynyl)benzoate (III), which is reduced with H2 over Pd/C to the 4-hydroxybutyl derivative (IV). The oxidation of (IV) with NaOCl and 2,2,6,6-tetramethyl-1-piperidinyloxy free radical (TEMPO) yields the corresponding aldehyde (V), which is brominated with 5,5-dibromobarbituric acid (DBBA) and HBr in acetic acid/dichloromethane affording the alpha-bromoaldehyde (VI). The cyclization of (VI) with 2,6-diaminopyrimidin-4(3H)-one (VII) by means of NaOAc in acetonitrile/water gives the pyrrolopyrimidine (VIII), which is hydrolyzed with aqueous NaOH and acidified with aqueous HCl yielding the benzoic acid derivative (IX). The condensation of (IX) with L-glutamic acid diethyl ester (X) by means of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and NMM in DMF affords the diethyl ester (XI) of pemetrexed, which is finally hydrolyzed with aqueous NaOH.

1 Kjell, D.P.; Slattery, B.J.; Improved route to multitargeted antifolate LY231514. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst ORG 130.
2 Kobierski, M.E.; Wilson, T.M.; Barnett, C.J.; A practical synthesis of multitargeted antifolate LY231514. Org Process Res Dev 1999, 3, 3, 184.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10168 4-Bromobenzoic acid methyl ester; methyl 4-bromobenzoate 619-42-1 C8H7BrO2 详情 详情
(II) 32507 3-butyn-1-ol 927-74-2 C4H6O 详情 详情
(III) 35243 methyl 4-(4-hydroxy-1-butynyl)benzoate C12H12O3 详情 详情
(IV) 35241 methyl 4-(4-hydroxybutyl)benzoate C12H16O3 详情 详情
(V) 14808 methyl 4-(4-oxobutyl)benzoate C12H14O3 详情 详情
(VI) 35242 methyl 4-(3-bromo-4-oxobutyl)benzoate C12H13BrO3 详情 详情
(VII) 14277 2,6-Diamino-4(3H)-pyrimidinone C4H6N4O 详情 详情
(VIII) 14812 methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate C16H16N4O3 详情 详情
(IX) 14805 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid C15H14N4O3 详情 详情
(X) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XI) 14807 diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate C24H29N5O6 详情 详情

合成路线9

该中间体在本合成路线中的序号:(I)

The condensation of L-glutamic acid diethyl ester (I) with 4-nitrophthalic anhydride (II) by means of DIEA in refluxing toluene gives the 4-nitrophthalimide (III), which is reduced with H2 over Pd/C to yield the 4-aminophthalimide (IV). The reduction of (IV) with Zn/HCl in ethanol affords a 3:1 mixture of the 5-aminoisoindolinone (V) and 6-aminoisoindolinone (VI) that is separated by chromatography. The desired isomer (V) is condensed with 9-(bromomethyl)-3-methylbenzo[f]quinazolin-1(2H)-one (VII) (obtained by bromination of 3,9-dimethylbenzo[f]quinazolin-1(2H)-one (VIII) with NBS) in DMF at 110?C to provide the precursor (IX). Finally, the ester groups of (IX) are hydrolyzed with NaOH in methanol.

1 Pendergast, W.; Dickerson, S.H.; Johnson, J.V.; Ferone, R. (GlaxoSmithKline plc); Pharmaceutically active benzoquinazoline cpds.. EP 0535034; EP 1199307; JP 1993507704; US 5405851; US 5663337; US 6306865; WO 9119700 .
2 Pendergast, W.; et al.; Benzo[f]quinazoline inhibitors of thymidylate synthase: Methyleneamino-linked aroylglutamate derivatives. J Med Chem 1994, 37, 6, 838.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(II) 31028 5-nitro-2-benzofuran-1,3-dione 5466-84-2 C8H3NO5 详情 详情
(III) 56649 diethyl (2S)-2-(5-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate C17H18N2O8 详情 详情
(IV) 56650 diethyl (2S)-2-(5-amino-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate C17H20N2O6 详情 详情
(V) 56651 diethyl (2S)-2-(5-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate C17H22N2O5 详情 详情
(VI) 56652 diethyl (2S)-2-(6-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate C17H22N2O5 详情 详情
(VII) 56653 9-(bromomethyl)-3-methylbenzo[f]quinazolin-1(2H)-one C14H11BrN2O 详情 详情
(VIII) 56654 3,9-dimethylbenzo[f]quinazolin-1(2H)-one C14H12N2O 详情 详情
(IX) 56655 diethyl (2S)-2-(5-{[(3-methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate C31H32N4O6 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

Acylation of diethyl L-glutamate (I) with 5-bromo-4-methylthiophene-2-carboxylic acid (II) using EDC as the coupling reagent provided amide (III). Subsequent palladium-catalyzed coupling between bromothiophene (III) and ethynyl pyridopyrimidinone (IV) furnished the disubstituted acetylene (V), which was further hydrogenated to (VI) in the presence of Pd/C in trifluoroacetic acid. Finally, basic hydrolysis of the ethyl ester and pivaloyl groups of (VI) led to the title compound.

1 Varney, M.D.; Romines, W.H. (Agouron Pharmaceuticals, Inc.); Cpds. useful as antiproliferative agents and GARFT inhibitors. WO 9603406 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(II) 55966 5-bromo-4-methyl-2-thiophenecarboxylic acid C6H5BrO2S 详情 详情
(III) 55967 diethyl (2S)-2-{[(5-bromo-4-methyl-2-thienyl)carbonyl]amino}pentanedioate C15H20BrNO5S 详情 详情
(IV) 14282 N-(6-Ethynyl-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide C14H14N4O2 详情 详情
(V) 55968 diethyl (2S)-2-({[5-(2-{2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl}ethynyl)-4-methyl-2-thienyl]carbonyl}amino)pentanedioate C29H33N5O7S 详情 详情
(VI) 55969 diethyl (2S)-2-({[5-(2-{2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl}ethyl)-4-methyl-2-thienyl]carbonyl}amino)pentanedioate C29H41N5O7S 详情 详情

合成路线11

该中间体在本合成路线中的序号:(XX)

After removal of the Boc protecting group of (XIV), the resultant free amine spontaneously cyclized to the lactam (XV) in methanolic solution. Lactam (XV) was O-alkylated with trimethyloxonium fluoroborate, yielding the lactim ether (XVI), which was condensed with guanidine (XVII) to produce the pyridothiazine (XVIII). Hydrolysis of the ethyl ester of (XVIII), followed by coupling of the resultant acid (XIX) with L-glutamic acid diethyl ester (XX), furnished amide (XXI). The ester groups of (XXI) were finally hydrolyzed with NaOH to give the title compound.

1 Varney, M.D.; et al.; Protein structure-based design, synthesis, and biological evaluation of 5-thia-2, 6-diamino-4(3H)-oxopyrimidines: Potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition. J Med Chem 1997, 40, 16, 2502.
2 Varney, M.D.; Palmer, C.L.; Romines, W.H. (Agouron Pharmaceuticals, Inc.); Syntheses of optically pure cpds. useful as GARFT inhibitors and their intermediates. WO 9640674 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIV) 59504 dimethyl 2-({(1S)-1-{[(tert-butoxycarbonyl)amino]methyl}-3-[5-(ethoxycarbonyl)-2-thienyl]propyl}sulfanyl)malonate C21H31NO8S2 详情 详情
(XV) 59505 methyl (6S)-6-{2-[5-(ethoxycarbonyl)-2-thienyl]ethyl}-3-oxo-2-thiomorpholinecarboxylate C15H19NO5S2 详情 详情
(XVI) 59506 methyl (6S)-6-{2-[5-(ethoxycarbonyl)-2-thienyl]ethyl}-3-methoxy-5,6-dihydro-2H-1,4-thiazine-2-carboxylate C16H21NO5S2 详情 详情
(XVII) 14790 Guanidine 113-00-8 CH5N3 详情 详情
(XVIII) 59507 ethyl 5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thiophenecarboxylate C15H18N4O3S2 详情 详情
(XIX) 59508 5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thiophenecarboxylic acid C13H14N4O3S2 详情 详情
(XX) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XXI) 59509 diethyl (2S)-2-{[(5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thienyl)carbonyl]amino}pentanedioate C22H29N5O6S2 详情 详情

合成路线12

该中间体在本合成路线中的序号:(II)

Treatment of hexachlorocyclotriphosphazene (I) with L-glutamic acid diethyl ester (II) in toluene in the presence of Et3N provides the ethyl glutamate derivative of cyclotriphosphazene (III), which is then subjected to saponification with LiOH in H2O to furnish compound (IV) (alternatively, the same procedure can be followed by performing the reaction between (I) and L-glutamic acid dimethyl ester (V) to afford the methyl glutamate derivative of cyclotriphosphazene (VI), which is saponified under the same conditions as (III)). Finally, the target product is obtained by reaction of intermediate (IV) with platinum derivative (VII) by means of Ag2SO4 in water, followed by treatment with BaCl2.H2O and precipitation in acetone.

1 Cho, Y.; Sohn, Y.S.; Baek, H.; Lee, C.O.; Synthesis and antitumor activity of cyclotriphosphazene - (diamine)platinum (II) conjugates. Anti-Cancer Drugs 2000, 11, 9, 715.
2 Lee, C.O.; Sohn, Y.S.; Baek, H.G. (Il-Yang Pharmaceutical Co., Ltd.; Korea Institute of Science and Technology); Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same. EP 1082331; US 6221906; WO 0058321 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 50037 Phosphonitrilic Chloride; 1,3,5-Triaza-2,4,6-triphosphorin-2,2,4,4,6,6-hexachloride; Hexachlorotriphosphazene; Phosphonitrilic chloride trimer; 1,3,5,2,4,6-Triazatriphosphorine-2,2,4,4,6,6-hexachloride; Hexachlorocyclotriphosphazene 940-71-6 Cl6N3P3 详情 详情
(II) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(III) 50038 diethyl (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-4-ethoxy-1-(ethoxycarbonyl)-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate C54H96N9O24P3 详情 详情
(IV) 50039 dodecalithium (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-1-carboxylato-4-oxido-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate C30H36Li12N9O24P3 详情 详情
(V) 50040 dimethyl (2S)-2-aminopentanedioate C7H13NO4 详情 详情
(VI) 50041 dimethyl (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-4-methoxy-1-(methoxycarbonyl)-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate C42H72N9O24P3 详情 详情
(VII) 50042   C6H14I2N2Pt 详情 详情

合成路线13

该中间体在本合成路线中的序号:(XII)

Condensation of the mixed anhydride (XI) with diethyl L-glutamate (XII) produces amide (XIII). The ethyl ester groups of (XIII) are finally hydrolyzed by means of NaOH to provide the title compound.

1 Mcguire, J.J.; Zeng, Y.; Gangjee, A.; Kisliuk, R.L.; Synthesis of N-[4-[ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate. J Med Chem 2002, 45, 9, 1942.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 58987   C22H26N4O5 详情 详情
(XII) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(XIII) 58989 diethyl (2S)-2-[(4-{1-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)methyl]propyl}benzoyl)amino]pentanedioate C26H33N5O6 详情 详情

合成路线14

该中间体在本合成路线中的序号:(V)

 

1 Cen JD,Lu AF. 2006.Method for preparation of folic acid antagonist and its intermediate. 发明专利申请公开说明书, CN 1880316
2 Fan CW. Lin D. Shan YQ, et aL 2006. Preparation of pemetrexed from L-glutamic acid and 4-[2- (2-α-mino-4,7-dihydro-4-oxo-3h-pyrrolo-[2,3-d] pyrimidirr-5-yl) ethyl] benzoic acid. 发明专利申请公开说明书.CN 1840530
3 Lin D, Fan CW, Zhu YD, et al. 2006. Process for preparation of nitro compounds as intermediates for synthesizing pemetrexed. 发明专利申请公开说明书, CN 1827604
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 66570 methyl 4-(2-oxoethyl)benzoate   C10H10O3 详情 详情
(II) 66571 methyl 4-(2-hydroxy-3-nitropropyl)benzoate   C11H13NO5 详情 详情
(III) 66572 4-(2-hydroxy-3-nitropropyl)benzoic acid   C10H11NO5 详情 详情
(IV) 66573 4,6-dimethoxy-1,3,5-triazin-2-yl 4-(2-hydroxy-3-nitropropyl)benzoate   C15H16N4O7 详情 详情
(V) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(VI) 66574 (2R)-diethyl 2-(4-(2-hydroxy-3-nitropropyl)benzamido)pentanedioate   C19H26N2O8 详情 详情
(VII) 66575 (R,E)-diethyl 2-(4-(3-nitroallyl)benzamido)pentanedioate   C19H24N2O7 详情 详情
(VIII) 66576 (2R)-diethyl 2-(4-(2-(4,6-diamino-2-oxo-1,2-dihydropyridin-3-yl)-3-nitropropyl)benzamido)pentanedioate   C24H31N5O8 详情 详情

合成路线15

该中间体在本合成路线中的序号:(V)

 

1 Taylor EC, Liu B 2000. Process for the preparation of pyrrolo [2,3-d] pyrirnidines. W0 2000011004
2 Taylor EC, Liu R. 2002. A new and efficient synthesis of pyrrolo [2,3-d] pyrimidines. anticancer agents: alimta (LY231514, MTA), homo-alimta, TNP-351, and some aryl 5-substituted pyrrolo [2,3-d] pyrimidines. J Org Chem, 68: 9938~9947
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14800 ethyl 4-(3-oxopropyl)benzoate C12H14O3 详情 详情
(II) 66577 (E)-ethyl 4-(4-nitrobut-3-en-1-yl)benzoate   C13H15NO4 详情 详情
(III) 66578 ethyl 4-(3-(2,4-diamino-6-hydroxypyrimidin-5-yl)-4-nitrobutyl)benzoate   C17H21N5O5 详情 详情
(IV) 66579 4-(2-(2-amino-4-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid   C15H14N4O3 详情 详情
(V) 11013 diethyl (2S)-2-aminopentanedioate C9H17NO4 详情 详情
(VI) 14807 diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate C24H29N5O6 详情 详情
Extended Information